Average Co-Inventor Count = 1.86
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neotherapeutics, Inc. (7 from 7 patents)
2. Spectrum Pharmaceuticals, Inc. (6 from 38 patents)
3. Other (5 from 832,680 patents)
4. Merck Eprova Ag (1 from 6 patents)
5. Sprectrum Pharmaceuticals, Inc. (1 from 1 patent)
20 patents:
1. 8734818 - Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
2. 8377456 - Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
3. 8063233 - Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
4. 7531670 - Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
5. 6982269 - Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
6. 6849735 - Methods of synthesis for 9-substituted hypoxanthine derivatives
7. 6770638 - Tetrahydroindolone and purine derivatives linked to arylpiperazines
8. 6759427 - Synthesis and methods of use of tetrahydroindolone analogues and derivatives
9. 6630490 - Methods for treatment of disease-induced peripheral neuropathy and related conditions
10. 6630478 - Methods for treatment of drug-induced peripheral neuropathy
11. 6407237 - Crystal forms of 9-substituted hypoxanthine derivatives
12. 6350752 - Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
13. 6338963 - Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
14. 6303617 - Serotonin-like 9-substituted hypoxanthine and methods of use
15. 6297226 - Synthesis and methods of use of 9-substituted guanine derivatives